Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment

• Frank L J Visseren,
• Steven H J Hageman,
• Stian Lydersen,
• Hanne Ellekjaer,
• Ingvild Saltvedt,
• Jannick A N Dorresteijn,
• Olav Spigset,
• Mari Nordbø Gynnild

Affiliations

Frank L J Visseren

University Medical Center Utrecht, Department of Vascular Medicine, Utrecht University, Utrecht, Utrecht, The Netherlands

Steven H J Hageman

1 Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

Stian Lydersen

Regional Centre for Child and Youth Mental Health and Child Welfare-Central Norway, Norwegian University of Science and Technology, Trondheim, Norway

Hanne Ellekjaer

Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology Faculty of Medicine and Health Sciences, Trondheim, Norway

Ingvild Saltvedt

Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway

Jannick A N Dorresteijn

University Medical Center Utrecht, Department of Vascular Medicine, Utrecht University, Utrecht, Utrecht, The Netherlands

Olav Spigset

1Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway

Mari Nordbø Gynnild

Department of Neuromedicine and Movement Science, Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, Trondheim, Norway